The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses
Author:
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.200838990/fullpdf
Reference38 articles.
1. CTLA-4 can function as a negative regulator of T cell activation;Walunas;Immunity,1994
2. BTLA: a new inhibitory receptor with a B7-like ligand;Carreno;Trends Immunol.,2003
3. New regulatory co-receptors: inducible co-stimulator and PD-1;Okazaki;Curr. Opin. Immunol.,2002
4. PD-L2 is a second ligand for PD-1 and inhibits T cell activation;Latchman;Nat. Immunol.,2001
5. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1;Watanabe;Nat. Immunol.,2003
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms;Scientific Reports;2024-05-31
2. The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling;Scientific Reports;2024-05-24
3. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma;Acta Neuropathologica Communications;2024-04-02
4. Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment;npj Aging;2024-02-06
5. Soluble vascular endothelial glycocalyx proteoglycans as potential therapeutic targets in inflammatory diseases;Immunology & Cell Biology;2023-11-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3